S. Lauttia

发表

Human breast cancer cells educate macrophages toward the M2 activation status

P. Kronqvist, H. Joensuu, P. Kellokumpu-Lehtinen, 2015, Breast Cancer Research.

Human breast cancer cells educate macrophages toward the M 2 activation status

P. Kronqvist, H. Joensuu, P. Kellokumpu-Lehtinen, 2022 .

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

M. Hauptmann, P. Nederlof, S. Linn, 2022, British Journal of Cancer.

Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma

H. Joensuu, V. Koljonen, H. Sihto, 2014, British Journal of Cancer.

Adjuvant Capecitabine-Containing Chemotherapy Benefit and Homologous Recombination Deficiency Status Among Early-Stage TNBC Patients in the FinXX trial

M. Hauptmann, P. Nederlof, S. Linn, 2020 .

BONE MARROW-DERIVED CELLS IN ANGIOGENESIS AND CANCER

S. Lauttia, 2014 .

The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.

P. Salvén, N. Zhang, R. Grénman, 2009, Microvascular research.

Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial

T. Nielsen, E. Thompson, H. Joensuu, 2020, Clinical Cancer Research.

Human breast cancer cells educate macrophages toward the M2 activation status

P. Kronqvist, H. Joensuu, P. Kellokumpu-Lehtinen, 2015, Breast Cancer Research.